MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01802nam a22002417a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
ISI Library, Kolkata |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240904112811.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
240726b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9241207256 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
ISI Library |
| Language of cataloging |
English |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
100 SD:610.621 |
| Item number |
WHO.Tr.725 |
| 110 1# - MAIN ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
WHO Expert Committee on Biological Standardization |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
WHO Expert Committee on Biological Standardization : thirty-fifth report, meeting held in Geneva from l1 to 18 June 1984 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Gerneva : |
| Name of publisher, distributor, etc |
World Health Organization, |
| Date of publication, distribution, etc |
1985 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
140 Pages: |
| Other physical details |
tables; |
| Dimensions |
20 cm. |
| 490 0# - SERIES STATEMENT |
|---|
| Series statement |
World Health Organization technical report series ; no. 725 |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
General -- Substances : Anibiotics -- Antibodies -- Antigens -- Blood products and related substances -- Endocrinological and related substances -- Miscellaneous -- Requirements for biological substances -- Acknowledgements -- Annexes |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Records the work and recommendations of an expert committee concerned with establishing and maintaining international standards and reference reagents for selected biologicals. Sections announce substances newly accepted as international standards or reference reagents, those replacing previous ones, and substances newly selected for collaborative studies. Annexed to the report are extensive sections on the standardization of interferons and amendments to WHO requirements No. 8-10 for diphtheria toxoid, pertussis vaccine, tetanus toxoid, and combined vaccines. Other annexes cover revised requirements for hepatitis B vaccine prepared from plasma and new requirements for live varicella vaccine |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Biological Products |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacology, Toxicology and Clinical Technology |
| 710 1# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
World Health Organization |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Reports |
